collection
https://read.qxmd.com/read/26517185/social-cognition-in-schizophrenia-from-evidence-to-treatmentedited-by-roberts-david-l-and-penn-david-l-new-york-oxford-university-press-2012-448-pp-79-99
#1
https://read.qxmd.com/read/26464841/the-effects-of-group-psychoeducational-programme-on-attitude-toward-mental-illness-in-families-of-patients-with-schizophrenia-2014
#2
JOURNAL ARTICLE
Farnaz Rahmani, Fatemeh Ranjbar, Hossein Ebrahimi, Mina Hosseinzadeh
INTRODUCTION: Family members often play a vital role as caregivers in the lives of individuals with schizophrenia. RESULTS of the studies showed that family invironment is the most important determinint of patients outcomes like as quality of life, relapse, adherence. This study aimed to determine the effect of group psychoeducational programme on attitude towards mental illness in families of patients with schizophrenia. METHODS: In this quasi-experimental study, 74 families who have schizophrenic patients hospitalized in psychiatric wards during sampling were selected by convenience sampling method...
2015: Journal of Caring Sciences
https://read.qxmd.com/read/25143294/cognitive-effects-of-very-low-nicotine-content-cigarettes-with-and-without-nicotine-replacement-in-smokers-with-schizophrenia-and-controls
#3
JOURNAL ARTICLE
Christopher G AhnAllen, L Cinnamon Bidwell, Jennifer W Tidey
INTRODUCTION: Beneficial effects of nicotine on cognitive functioning may contribute to the markedly high rates of smoking among people with schizophrenia. A reduction in the nicotine content of cigarettes to non-addictive levels is being considered as a regulatory strategy for reducing tobacco dependence in the United States. We examined whether switching to very low nicotine content (VLNC) cigarettes impairs cognitive functioning in smokers with and without schizophrenia, andwhether nicotine replacement reverses these effects...
May 2015: Nicotine & Tobacco Research
https://read.qxmd.com/read/23810019/comparative-efficacy-and-tolerability-of-15-antipsychotic-drugs-in-schizophrenia-a-multiple-treatments-meta-analysis
#4
REVIEW
Stefan Leucht, Andrea Cipriani, Loukia Spineli, Dimitris Mavridis, Deniz Orey, Franziska Richter, Myrto Samara, Corrado Barbui, Rolf R Engel, John R Geddes, Werner Kissling, Marko Paul Stapf, Bettina Lässig, Georgia Salanti, John M Davis
BACKGROUND: The question of which antipsychotic drug should be preferred for the treatment of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a hierarchy based on the randomised evidence. We aimed to integrate the available evidence to create hierarchies of the comparative efficacy, risk of all-cause discontinuation, and major side-effects of antipsychotic drugs. METHODS: We did a Bayesian-framework, multiple-treatments meta-analysis (which uses both direct and indirect comparisons) of randomised controlled trials to compare 15 antipsychotic drugs and placebo in the acute treatment of schizophrenia...
September 14, 2013: Lancet
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.